Logo image of SLDE

SLIDE INSURANCE HOLDINGS INC (SLDE) Stock Fundamental Analysis

USA - NASDAQ:SLDE - US8313491057 - Common Stock

14.875 USD
-0.07 (-0.5%)
Last: 10/21/2025, 9:32:38 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SLDE. SLDE was compared to 147 industry peers in the Insurance industry. There are concerns on the financial health of SLDE while its profitability can be described as average. SLDE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SLDE had positive earnings in the past year.
SLDE Yearly Net Income VS EBIT VS OCF VS FCFSLDE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

SLDE's Return On Assets of 9.07% is amongst the best of the industry. SLDE outperforms 95.92% of its industry peers.
With an excellent Return On Equity value of 29.40%, SLDE belongs to the best of the industry, outperforming 96.60% of the companies in the same industry.
With an excellent Return On Invested Capital value of 9.59%, SLDE belongs to the best of the industry, outperforming 93.88% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SLDE is above the industry average of 4.46%.
The last Return On Invested Capital (9.59%) for SLDE is above the 3 year average (7.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.07%
ROE 29.4%
ROIC 9.59%
ROA(3y)7.23%
ROA(5y)N/A
ROE(3y)33.23%
ROE(5y)N/A
ROIC(3y)7.63%
ROIC(5y)N/A
SLDE Yearly ROA, ROE, ROICSLDE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 10 20 30 40

1.3 Margins

SLDE has a Profit Margin of 26.00%. This is amongst the best in the industry. SLDE outperforms 95.92% of its industry peers.
The Operating Margin of SLDE (35.59%) is better than 98.64% of its industry peers.
Industry RankSector Rank
OM 35.59%
PM (TTM) 26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLDE Yearly Profit, Operating, Gross MarginsSLDE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SLDE is creating some value.
The number of shares outstanding for SLDE remains at a similar level compared to 1 year ago.
The debt/assets ratio for SLDE has been reduced compared to a year ago.
SLDE Yearly Shares OutstandingSLDE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SLDE Yearly Total Debt VS Total AssetsSLDE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

A Debt/Equity ratio of 0.04 indicates that SLDE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, SLDE belongs to the top of the industry, outperforming 85.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.11
WACC8.64%
SLDE Yearly LT Debt VS Equity VS FCFSLDE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SLDE Yearly Current Assets VS Current LiabilitesSLDE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

SLDE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 130.22%, which is quite impressive.
SLDE shows a strong growth in Revenue. In the last year, the Revenue has grown by 80.74%.
EPS 1Y (TTM)130.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SLDE will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.56% on average per year.
SLDE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.56% yearly.
EPS Next Y58.29%
EPS Next 2Y27.12%
EPS Next 3Y19.56%
EPS Next 5YN/A
Revenue Next Year32.26%
Revenue Next 2Y20.81%
Revenue Next 3Y16.56%
Revenue Next 5YN/A

3.3 Evolution

SLDE Yearly Revenue VS EstimatesSLDE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLDE Yearly EPS VS EstimatesSLDE Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.29 indicates a rather cheap valuation of SLDE.
75.51% of the companies in the same industry are more expensive than SLDE, based on the Price/Earnings ratio.
SLDE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
SLDE is valuated cheaply with a Price/Forward Earnings ratio of 5.72.
Based on the Price/Forward Earnings ratio, SLDE is valued a bit cheaper than the industry average as 78.91% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.18. SLDE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.29
Fwd PE 5.72
SLDE Price Earnings VS Forward Price EarningsSLDE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLDE indicates a rather cheap valuation: SLDE is cheaper than 89.80% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.71
SLDE Per share dataSLDE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SLDE's earnings are expected to grow with 19.56% in the coming years.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y27.12%
EPS Next 3Y19.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLDE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLIDE INSURANCE HOLDINGS INC

NASDAQ:SLDE (10/21/2025, 9:32:38 AM)

14.875

-0.07 (-0.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-05 2025-11-05
Inst Owners24.38%
Inst Owner Change-1.44%
Ins Owners43.27%
Ins Owner Change30.64%
Market Cap1.87B
Analysts81.82
Price Target21.42 (44%)
Short Float %3.13%
Short Ratio2.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.94%
PT rev (3m)N/A
EPS NQ rev (1m)20.15%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.64%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.29
Fwd PE 5.72
P/S 1.9
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.17
EV/EBITDA 2.71
EPS(TTM)2.04
EY13.71%
EPS(NY)2.6
Fwd EY17.49%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.82
BVpS6.92
TBVpS6.87
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.07%
ROE 29.4%
ROCE 12.9%
ROIC 9.59%
ROICexc 14.66%
ROICexgc 25.13%
OM 35.59%
PM (TTM) 26%
GM N/A
FCFM N/A
ROA(3y)7.23%
ROA(5y)N/A
ROE(3y)33.23%
ROE(5y)N/A
ROIC(3y)7.63%
ROIC(5y)N/A
ROICexc(3y)10.71%
ROICexc(5y)N/A
ROICexgc(3y)20.87%
ROICexgc(5y)N/A
ROCE(3y)10.26%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 0.1
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACC8.64%
ROIC/WACC1.11
Cap/Depr(3y)95.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.74%
Cap/Sales(5y)N/A
Profit Quality(3y)482.81%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y58.29%
EPS Next 2Y27.12%
EPS Next 3Y19.56%
EPS Next 5YN/A
Revenue 1Y (TTM)80.74%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year32.26%
Revenue Next 2Y20.81%
Revenue Next 3Y16.56%
Revenue Next 5YN/A
EBIT growth 1Y128.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.6%
EBIT Next 3Y17.74%
EBIT Next 5YN/A
FCF growth 1Y25.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.03%
OCF growth 3YN/A
OCF growth 5YN/A